摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(±)-(6-{2,5,7,8-tetramethyl-2-[4-(3-methyl-2,4-dioxothiazolidin-(5Z)-ylidenemethyl)phenoxymethyl]chroman-6-yl}hexyl)carbamic acid tert-butyl ester | 1621470-75-4

中文名称
——
中文别名
——
英文名称
(±)-(6-{2,5,7,8-tetramethyl-2-[4-(3-methyl-2,4-dioxothiazolidin-(5Z)-ylidenemethyl)phenoxymethyl]chroman-6-yl}hexyl)carbamic acid tert-butyl ester
英文别名
——
(±)-(6-{2,5,7,8-tetramethyl-2-[4-(3-methyl-2,4-dioxothiazolidin-(5Z)-ylidenemethyl)phenoxymethyl]chroman-6-yl}hexyl)carbamic acid tert-butyl ester化学式
CAS
1621470-75-4
化学式
C36H48N2O6S
mdl
——
分子量
636.853
InChiKey
KIEMICOFAUISMW-OFWBYEQRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    112-114 °C
  • 密度:
    1.161±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.07
  • 重原子数:
    45.0
  • 可旋转键数:
    11.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    94.17
  • 氢给体数:
    1.0
  • 氢受体数:
    7.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (±)-(6-{2,5,7,8-tetramethyl-2-[4-(3-methyl-2,4-dioxothiazolidin-(5Z)-ylidenemethyl)phenoxymethyl]chroman-6-yl}hexyl)carbamic acid tert-butyl ester三氟乙酸二氯甲烷 为溶剂, 反应 3.0h, 以54%的产率得到(±)-(5Z)-{4-[6-(6-aminohexyl)-2,5,7,8-tetramethylchroman-2-ylmethoxy]benzylidene}-3-methylthiazolidine-2,4-dione trifluoroacetic acid salt
    参考文献:
    名称:
    Optimization of troglitazone derivatives as potent anti-proliferative agents: Towards more active and less toxic compounds
    摘要:
    Δ2-Troglitazone derivatives were shown to exhibit anti-proliferative activity in a PPARγ-independent manner. We prepared various compounds in order to increase their potency and decrease their toxicity towards non-malignant primary cultured hepatocytes. Many compounds induced viabilities less than 20% at 10 μM on various cancer cell lines. Furthermore, five of them showed hepatocyte viability of 80% or more at 200 μM. In addition, compounds 17 and 18 exhibited promising maximum tolerated doses on a murine model, enabling future investigations.
    DOI:
    10.1016/j.ejmech.2014.06.015
  • 作为产物:
    描述:
    6-溴己酰氯哌啶吡啶 、 aluminum (III) chloride 、 lithium aluminium tetrahydride 、 sodium azide 、 palladium on activated charcoal 、 氢气potassium carbonate苯甲酸 作用下, 以 甲醇乙醚二氯甲烷N,N-二甲基甲酰胺甲苯 为溶剂, 反应 59.33h, 生成 (±)-(6-{2,5,7,8-tetramethyl-2-[4-(3-methyl-2,4-dioxothiazolidin-(5Z)-ylidenemethyl)phenoxymethyl]chroman-6-yl}hexyl)carbamic acid tert-butyl ester
    参考文献:
    名称:
    Optimization of troglitazone derivatives as potent anti-proliferative agents: Towards more active and less toxic compounds
    摘要:
    Δ2-Troglitazone derivatives were shown to exhibit anti-proliferative activity in a PPARγ-independent manner. We prepared various compounds in order to increase their potency and decrease their toxicity towards non-malignant primary cultured hepatocytes. Many compounds induced viabilities less than 20% at 10 μM on various cancer cell lines. Furthermore, five of them showed hepatocyte viability of 80% or more at 200 μM. In addition, compounds 17 and 18 exhibited promising maximum tolerated doses on a murine model, enabling future investigations.
    DOI:
    10.1016/j.ejmech.2014.06.015
点击查看最新优质反应信息